Sierra Oncology

Sierra Oncology

Verified
Sierra Oncology | Targeted Cancer Treatments | Home

Launch date
Employees
Market cap
$1.3b
Net debt
-
Firm valuation
$1.9b (Public information from Apr 2022)
Canada (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Profit----(72.7m)--
R&D budget30m25m36m47m---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
$775kEarly VC
$1.1mEarly VC
$2.5mEarly VC
$12.5mEarly VC
N/A$1.7mEarly VC
N/A$4.3mDebt
$12mSeries C
$59.5mSeries D
N/A$2.7mDebt
N/A$107m
Valuation: $410m
IPO
N/A$103mPost IPO Equity
N/A$34mPost IPO Equity
*
N/A$135mSecondary
*
$1.9b
Valuation: $1.9b
Acquisition
Total Funding$90.1m

Recent News about Sierra Oncology

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.